We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Ventricular Dysfunction Algorithm Predicts Cardiac Surgery Survival

By HospiMedica International staff writers
Posted on 11 Jan 2022
Print article
Image: AI can help identify mortality risk in cardiac surgery patients (Photo courtesy of Shutterstock)
Image: AI can help identify mortality risk in cardiac surgery patients (Photo courtesy of Shutterstock)
An artificial intelligence (AI) algorithm can predict long-term mortality among patients undergoing valve and/or coronary bypass surgery, according to a new study.

Researchers at the Mayo Clinic (Rochester, MN, USA) conducted a study that included 20,627 patients who underwent valve or coronary bypass surgery between 1993 and 2019, with a left ventricular ejection fraction (LVEF) higher than 35%. Patients were screened using an AI-enhanced electrocardiogram (AI-ECG) to independently detect severe ventricular dysfunction on a preoperative electrocardiography, with the primary end being all-cause mortality following cardiac surgery.

The results showed that 83% of patients had a normal AI-ECG screen, and 17% had an abnormal one; patients with an abnormal AI-ECG screen were older and had more comorbidities. The probability of five and ten survival was 86.2% and 68.2% in those with normal AI-ECG screen, compared to 71.4% and 45.1% in abnormal screening. Abnormal AI-ECG screening was independently associated with higher all-cause mortality, and was consistent in patients with an LVEF of 35-55% and those with an LVEF above 55%. The study was published in the December 2021 issue of Mayo Clinic Proceedings.

“The analysis showed that an abnormal AI screen was associated with a 30% increase in long-term mortality after valve or coronary bypass surgery. This correlation was consistent among patients undergoing valve, coronary bypass, or valve and coronary bypass surgery,” said senior author Mohamad Alkhouli, MD. “For clinicians, this may aid in risk stratification of patients referred for surgery and facilitate shared decision-making.”

LVEF is the measurement of how much blood is being pumped out of the left ventricle of the heart with each contraction, and is usually expressed as a percentage. A normal LVEF ranges from 55-70%. An LVEF of less than 40% may confirm a diagnosis of HF. An EF of less than 35% increases the risk of an arrhythmia that can cause sudden cardiac arrest or death, and an ICD may be recommended for these patients.

Related Links:
Mayo Clinic

Print article


Surgical Techniques

view channel
Image: Resolute Onyx DES helps address all DES needs and numerous patient anatomies (Photo courtesy of Medtronic)

Medtronic’s Latest Generation Drug-Eluting Coronary Stent System Offers Dual-Layer Balloon Technology

Coronary artery disease (CAD) is one of the leading causes of death and is caused by plaque buildup on the inside of the coronary arteries. These plaque deposits can narrow or clog the inside of the arteries,... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.